Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Research in Developmental Disabilities
|
April 24, 2012
Neurodevelopmental problems in maltreated children referred with indiscriminate friendliness
Eva Kočovská, Christine Puckering, Michael Follan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 13, 2025
Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials
Arlene D'Silva, James Barnes, Jason Djafar, et al.
Mbio
|
February 13, 2020
Universal Dermal Microbiome in Human Skin
Lene Bay, Christopher James Barnes, Blaine Gabriel Fritz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
February 6, 2024
Spectroscopic and Microscopic Characterization of Microbial Biofouling on Aircraft Fuel Tanks
Jaime Gómez-Bolívar, Martin P Warburton, Adam D Mumford, et al.
Msphere
|
May 9, 2025
Unique dermal bacterial signature differentiates atopic dermatitis skin from healthy
Lene Bay, Christopher James Barnes, Blaine Gabriel Fritz, et al.
NPJ Vaccines
|
November 9, 2021
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
NPJ Vaccines
|
January 6, 2022
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
Neuroscience and Biobehavioral Reviews
|
May 4, 2023
Understanding visual hallucinations: A new synthesis
Daniel Collerton, James Barnes, Nico J Diederich, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Journal of Infectious Diseases
|
November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Research in Developmental Disabilities
|
April 24, 2012
Neurodevelopmental problems in maltreated children referred with indiscriminate friendliness
Eva Kočovská, Christine Puckering, Michael Follan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 13, 2025
Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials
Arlene D'Silva, James Barnes, Jason Djafar, et al.
Mbio
|
February 13, 2020
Universal Dermal Microbiome in Human Skin
Lene Bay, Christopher James Barnes, Blaine Gabriel Fritz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
February 6, 2024
Spectroscopic and Microscopic Characterization of Microbial Biofouling on Aircraft Fuel Tanks
Jaime Gómez-Bolívar, Martin P Warburton, Adam D Mumford, et al.
Msphere
|
May 9, 2025
Unique dermal bacterial signature differentiates atopic dermatitis skin from healthy
Lene Bay, Christopher James Barnes, Blaine Gabriel Fritz, et al.
NPJ Vaccines
|
November 9, 2021
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
NPJ Vaccines
|
January 6, 2022
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, et al.
Neuroscience and Biobehavioral Reviews
|
May 4, 2023
Understanding visual hallucinations: A new synthesis
Daniel Collerton, James Barnes, Nico J Diederich, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Journal of Infectious Diseases
|
November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Page
of 6